Onconova Announces Presentation of Rigosertib Clinical Data

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Onconova Announces Presentation of Rigosertib Clinical Data in Myelodysplastic Syndromes (MDS) at the 2013 ASH Annual Meeting

NEWTOWN, Pa., Nov. 7, 2013 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq: ONTX ), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, today announced two presentations relating to clinical trials of its most advance product candidate, rigosertib, at the 55 th American Society of Hematology (ASH) Annual Meeting in New Orleans, Louisiana, December 7-10, 2013. The presentations will include data on efficacy, tolerability, and dosing regimen from the Phase 2 study (ONTARGET) of oral rigosertib in transfusion-dependent, lower risk MDS patients and response, overall survival, and longer-term follow-up data from a Phase 1/2 trial of IV rigosertib in higher risk post-hypomethylating agent treated MDS and AML patients.

Details for the presentations are as follows:

Abstract #2745

Oral Rigosertib (ON 01910.Na) Treatment Produces An Encouraging Rate Of Transfusion Independence In Lower Risk Myelodysplastic Syndromes (MDS) Patients; A Genomic Methylation Profile Is Associated With Responses

Date: Sunday, December 8, 2013
Time:  6:30 PM - 8:30 PM
Session:  633. Myelodysplastic Syndromes: Poster II
Location:  Ernest N. Morial Convention Center, Hall E
Presenter:  Azra Raza, MD, MDS Center, Columbia University Medical Center, New York, NY

Abstract #1527

Predictors Of Response To Rigosertib In Patients With a Myelodysplastic Syndrome (MDS) Or Acute Myeloid Leukemia (AML) Relapsing After Or Refractory To Hypomethylating Agents

Date:  Saturday, December 7, 2013
Time:  5:30 PM - 7:30 PM 
Session:  633. Myelodysplastic Syndromes: Poster I
Location:  Ernest N. Morial Convention Center, Hall E 
Presenter:  Shyamala C. Navada, MD, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY

About Onconova Therapeutics, Inc.

Onconova Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer. Onconova's clinical and pre-clinical stage drug development candidates are derived from its extensive chemical library and are designed to work against specific cellular pathways that are important in cancer cells, while causing minimal damage to normal cells. In addition to rigosertib, the Company's most advanced product candidate, two other candidates are in clinical trials, and several candidates are in pre-clinical stages.  For more information, please visit  http://www.onconova.com .

Onconova Therapeutics Benjamin Hoffman, 267-759-3680 or Media: MacDougall Biomedical Communications Chris Erdman, 781-235-3060

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 9

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 12

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading
LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 13

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading
Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 11

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 10

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading
Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 13

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading
Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 11

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading

Top 5 Most Recently Viewed Articles

Kansas Speaks Survey Reveals Public Opinions in 2025

Updated Category News Views 255

Insights from the 2025 Kansas Speaks Survey The Docking Institute of Public Affairs has recently published the newest findings from the Kansas Speaks Survey. This comprehensive survey, which reached out to 526 Kansas residents aged 18 and older, aims to gauge public opinion on a variety of important topics affecting the state. Survey Topics Explored This year's survey...

Continue Reading
Nozomi Networks Achieves Recognition in Deloitte Fast 500 Rankings

Updated Category News Views 216

Nozomi Networks Celebrates Growth Recognition Continued dedication to addressing the unique challenges of OT, IoT, and CPS cybersecurity has propelled impressive company growth. SAN FRANCISCO — Nozomi Networks, a leader in operational technology (OT), Internet of Things (IoT), and cyber-physical systems (CPS) security, proudly announces its inclusion in the Deloitte...

Continue Reading
Cryptocurrency Market Trends: Should You Sell Now?

Updated Category News Views 132

Market Trends in Cryptocurrency In recent days, Bitcoin (CRYPTO: BTC), Ethereum (CRYPTO: ETH), and XRP (CRYPTO: XRP) have witnessed significant declines, raising concerns among investors about whether it's time to panic sell. While market fluctuations are common, understanding the trends can help investors make informed decisions. Bitcoin's Current Position Bitcoin's...

Continue Reading
AAPS Challenges Government's Overreach with New Lawsuit

Updated Category News Views 148

Introduction to AAPS's Lawsuit The Association of American Physicians and Surgeons (AAPS) has taken a significant step to protect the privacy of millions of Americans. With a recent lawsuit announced, AAPS aims to block the requirement set to take effect requiring individuals to provide extensive personal information to federal agencies. This initiative is part of the...

Continue Reading
Redwood Living Celebrates Recent Success in Industry Rankings

Updated Category News Views 298

Redwood Living's Outstanding Achievements in Rankings Redwood Living, Inc. has recently made headlines with its notable performance in the competitive landscape of multifamily housing. Securing the #8 position in the Division III Power Rankings for the ORA® (Online Reputation Assessment) is a significant achievement, reflecting the company’s dedication to excellence in...

Continue Reading